"estrogen receptor negative breast cancer" trang 11 - tải miễn phí từ tailieunhanh
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
14    29    1
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas

Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas
13    36    1
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
10    28    1
17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells

17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells
14    30    1
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression

Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression
10    43    1
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
15    23    1
Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer
9    61    1
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
10    62    1
Metabolic characterization of triple negative breast cancer

Metabolic characterization of triple negative breast cancer
12    31    1
Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol

Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol
10    30    1
NILCO biomarkers in breast cancer from Chinese patients

NILCO biomarkers in breast cancer from Chinese patients
12    59    1
Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover

Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover
14    39    1
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
16    28    1
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
10    41    1
Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer
13    40    1
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: Results from a German population-based case-control study

Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: Results from a German population-based case-control study
9    44    1
Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86

Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86
13    47    1
Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
16    44    1
Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland

Case report: Anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland
4    46    1
ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
16    70    1